1. Introduction {#sec1}
===============

The human herpes virus-8 (HHV-8), also called Kaposi\'s sarcoma herpes virus (KSHV), is the causative agent of all types of Kaposi\'s sarcoma (KS), namely the classic, endemic, iatrogenic immunosuppression, and the epidemic/human immunodeficiency virus (HIV) related forms. The modes of acquisition of the KSHV and its transmission vary with age, gender, geography, and sexual practices \[[@B1]\]. Although the virus is omnipresent its incidence is highest in KS endemic regions such as sub-Saharan Africa (sSA).

In Uganda, HHV-8 DNA was detected in 28 percent of oral swabs and 27 percent of blood samples of healthy asymptomatic subjects \[[@B2]\]. Hence, saliva is a potential source of transmission. KSHV is transmitted to children from maternal and nonmaternal sources in KS-endemic regions, and occurs via nonsexual routes \[[@B3]--[@B6]\]. It has been shown that, in sSA, infection occurs during childhood mainly via maternal saliva and breast milk \[[@B7], [@B8]\]. Anthropologic research in sSA has identified that premastication of foods of infants and children is traditional, and that saliva, semen, and vaginal fluids are used while engaging in nonsexual practices associated with childcare \[[@B9]--[@B11]\].

The sexual transmission of KSHV is more controversial. In the industrialized world, there is evidence of transmission between men having sex with men (MSM) via anal but not oroanal sex \[[@B7], [@B12], [@B13]\]. Heterosexual transmission is affirmed by some \[[@B14]--[@B18]\]. Others deny it \[[@B5], [@B19]\]. Since KSHV is present in semen and in uterine cervical scrapings, sexual transmission appears to be very plausible \[[@B17], [@B20], [@B21]\]. However, despite the high incidence of KSHV infection and its presence in the male and female genital tract, surprisingly few cases of anogenital KS have been reported in the literature, associated or not with HIV coinfection, in males or females \[[@B22]--[@B27]\].

The purpose of this study was to describe the clinical and histopathological spectrum of anogenital lesions either under- or overdiagnosed as KS in a HIV/AIDS endemic province of South Africa.

2. Materials and Methods {#sec2}
========================

The study was carried out at the Histopathology Department of the National Health Laboratory Service of the Limpopo Province. The population is mainly rural and is in excess of 5 M. The department receives and reports all the histology specimens from the public hospitals in the province.

The cases were retrieved from a prospective survey of 429 biopsy and LAN-1 immunohistochemically stained cases from March 2010 through July 2012 ([Figure 1](#fig1){ref-type="fig"}). Patients\' data were recorded from the biopsy request form and the laboratory data base. The following information was compiled: age, gender, clinical information, clinical provisional diagnosis, and HIV serostatus.

Routine streptavidin-biotin-peroxidase immunostaining with diaminobenzidine was performed on formalin-fixed paraffin-embedded tissue using a murine monoclonal antibody directed against the C-terminus of the latent nuclear antigen-1 (LNA-1) molecule of HHV-8 (clone 13B10; Novocastra, Newcastle upon Tyne, UK).

Patients\' anonymity was preserved. Ethical approval was obtained from the institutional research ethics committee.

3. Results {#sec3}
==========

[Figure 1](#fig1){ref-type="fig"} illustrates the distribution of cases by HIV status, immunohistochemically diagnosed KS, and mimicks. We collected a total of 36 cases of anogenital lesions: 15 in males and 21 in females. Sixteen (44.4%) had a documented HIV infection; 20 were of unknown HIV serostatus.

[Table 1](#tab1){ref-type="table"} shows the clinicopathology of male anogenital lesions. There were 4 KS and 11 mimicks; four (26.6%) were HIV-positive. Pyogenic granulomas accounted for 7 (46.6%) of non-KS lesions. KS was clinically suspected in one case only.

[Table 2](#tab2){ref-type="table"} illustrates the clinicopathological presentation of female anogenital lesions. Twelve (46.2%) were known to be HIV-positive. The clinical diagnosis of KS was made in cases with known disseminated KS.

4. Discussion {#sec4}
=============

African endemic KS has been identified for many decades in the past. Currently, the increasing prevalence of HIV infection complicates all efforts to clearly distinguish the endemic variant from the HIV-related one \[[@B28]\]. The clinical presentation and natural history of the endemic KS are now blending with those of the epidemic or AIDS-associated disease \[[@B29]\]. The distinction is clinically relevant because, although it is amenable to highly active antiretroviral treatment (HAART), AIDS-associated KS carries a poor prognosis \[[@B30]\]. Unfortunately, in South Africa, there is still widespread reluctance to be tested for HIV. This is attributable to the official opt-in policy (voluntary counseling and testing), and the fear of stigma and discrimination. This adds to the difficulty in distinguishing endemic from epidemic KS cases.

Early reports on African KS concentrated on the gender differences and histological features \[[@B31], [@B32]\]. One publication indicated that the most common presentation was cutaneous; it emphasised the rarity of anogenital location \[[@B33]\]. In a textbook of 1957, Bluefarb cited six patients with KS of the glans penis \[[@B34]\]. A series of 29 KS cases retrospectively collected from 1973 till 1985 in Uganda mentioned external genital involvement of 15 \[[@B35]\]. A Nigerian report mentioned that anogenital involvement was more common in HIV-positive cases \[[@B36]\]. A more recent publication of 66 biopsy-confirmed KS and HIV-seropositive patients found 10 (15.2%) genital sites (not otherwise specified); no genital KS was found in 11 cases of endemic KS \[[@B28]\]. Among twenty biopsy-proven Nigerian KS, the penis and rectum were involved in what appears to be cases of disseminated KS \[[@B37]\]. In an Ugandan series of 197 HIV-associated KS (only 62% biopsy-proven) it was reported that 6% were located on the genitals (no gender distribution or precise anatomic location); half of the series had lesions in two or more anatomic locations \[[@B38]\]. The difficulty with most of these reports is that the anogenital location seems to have been part of multicentric or disseminated KS, and that none was LNA-1 confirmed.

It is now well established that both the clinical and histological diagnosis of KS is fraught with over- and underdiagnosis because of the wide range of mimickers \[[@B39], [@B40]\]. Therefore, especially in HIV/AIDS and KS endemic areas, a clinical lesion suspect of KS should be biopsied, and the histopathological diagnosis must be supported by HHV-8 immunohistochemistry. Clinically, the most common mimicks are seborrheic keratosis, haemangioma, and pyogenic granulomas. Histopathologically, around thirty lesions are part of the differential diagnosis \[[@B39], [@B40]\]. Seborrheic keratosis mimicks early patch stage KS. Pyogenic granulomas and haemangioma mimick nodular stage KS. Fibrous histiocytoma and tendosynovitis mimick the plaque stage, to name only a few and most common ones.

Literature case reports all illustrate that vulvar KS appeared clinically as a mass, a papilloma, or an abscess; none was initially suspected to be a KS \[[@B22]--[@B26]\]. In the present series, KS was clinically diagnosed only in one instance; one was overdiagnosed microscopically as KS before LAN-1 immunostaining.

In conclusion, anogenital KS is rare and easily misdiagnosed even in HIV/KS endemic regions. Therefore, a high clinical suspicion threshold should prompt a biopsy, and the diagnosis of KS should be confirmed by LNA-1 immunohistochemistry to avoid misdiagnosis and wrong management.
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###### 

Clinicopathological presentation of anogenital lesions in males.

  Age   HIV Status   Clinical Presentation        Histopathology
  ----- ------------ ---------------------------- --------------------------------
  54    Unknown      Scrotal mass                 Nodular stage KS
  38    Positive     Perineal ulcer               Plaque stage KS
  29    Unknown      Penile ulcer                 Nodular stage KS
  35    Unknown      Penile KS                    Early patch stage KS
  49    Unknown      Scrotal ulcer                Pyogenic granuloma
  34    Positive     Scrotal ulcer                Pyogenic granuloma
  27    Unknown      Scrotal pyogenic granuloma   Pyogenic granuloma
  72    Unknown      Scrotal ulcer                Pyogenic granuloma
  30    Unknown      Penile ulcer                 Pyogenic granuloma
  59    Positive     Perianal ulcer               Pyogenic granuloma
  63    Unknown      Perianal ulcer               Pyogenic granuloma
  47    Unknown      Perianal nodule              Hemangioma
  24    Unknown      Scrotal nodule               Hemangioma
  32    Positive     Fournier\'s gangrene         Fournier\'s gangrene
  41    Unknown      Penile nodule                Malignant fibrous histiocytoma

###### 

Clinicopathologic presentation of anogenital lesions in females.

  Age   HIV Status   Clinical Presentation               Histopathology
  ----- ------------ ----------------------------------- ------------------------
  48    Positive     Vulvar mass                         Nodular stage KS
  31    Positive     Vulvar mass (disseminated **KS**)   Nodular stage KS
  33    Unknown      Cervical erosion                    Nodular stage KS
  34    Positive     Vulvar nodule                       Early patch stage KS
  24    Unknown      Vulvar nodule                       Nodular stage KS
  24    Positive     Vaginal **KS**                      Nodular stage KS
  19    Positive     Vulvar **KS**                       Pyogenic granuloma
  48    Unknown      Anal ulcer                          Pyogenic granuloma
  40    Unknown      Vaginal ulcer                       Pyogenic granuloma
  35    Positive     Vulvar nodule                       Pyogenic granuloma
  44    Positive     Vulvar nodule                       Pyogenic granuloma
  22    Negative     Vulvar nodule                       Pyogenic granuloma
  44    Positive     Anal ulcer                          Pyogenic granuloma
  25    Positive     Vulvar nodule                       Fibrous histiocytoma
  25    Positive     Vulvar carcinoma                    Fibrous histiocytoma
  49    Unknown      Vulvar nodule                       Fibrous histiocytoma
  58    Unknown      Cervical mass                       Pedunculated leiomyoma
  49    Unknown      Vulvar violaceous lesion            Lichen planus
  42    Positive     Vulvar dark skin patch              Melanocytic melanoma
  45    Positive     Vulvar nodule                       Hemangioma
  43    Unknown      Cervical erosion                    Cervical cancer
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